Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial

被引:221
|
作者
Derman, Richard J.
Kodkany, Bhalchandra S.
Goudar, Shivaprasad S.
Geller, Stacie E.
Naik, Vijaya A.
Bellad, M. B.
Patted, Shobhana S.
Patel, Ashlesha
Edlavitch, Stanley A.
Hartwell, Tyler
Chakraborty, Hrishikesh
Moss, Nancy
机构
[1] Univ Illinois, Coll Med, Dept Obstet & Gynecol MC 808, Chicago, IL 60612 USA
[2] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
[3] Jawaharlal Nehru Med Coll, Belgaum, Karnataka, India
[4] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA
[5] RTI Int, Stat & Epidemiol, Res Triangle Pk, NC USA
[6] NICHHD, Bethesda, MD 20892 USA
来源
LANCET | 2006年 / 368卷 / 9543期
关键词
D O I
10.1016/S0140-6736(06)69522-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Postpartum haemorrhage is a major cause of maternal mortality in the developing world. Although effective methods for prevention and treatment of such haemorrhage exist-such as the uterotonic drug oxytocin - most are not feasible in resource-poor settings where many births occur at home. We aimed to investigate whether oral misoprostol, a potential alternative to oxytocin, could prevent postpartum haemorrhage in a community home-birth setting. Methods In a placebo-controlled trial undertaken between September, 2002, and December, 2005, 1620 women in rural India were randomised to receive oral misoprostol (n=812) or placebo (n=808) after delivery. 25 auxiliary nurse midwives undertook the deliveries, administered the study drug, and measured blood loss. The primary outcome was the incidence of acute postpartum haemorrhage (defined as >= 500 mL bleeding) within 2 h of delivery. Analysis was by intention-to-treat. The trial was registered with the US clinical trials database (http://www.clinicaltrials.gov) as number NCT00097123. Findings Oral misoprostol was associated with a significant reduction in the rate of acute postpartum haemorrhage (12.0% to 6.4%, p < 0.0001; relative risk 0.53 [95% CI 0.39-0.74]) and acute severe postpartum haemorrhage (1.2% to 0.2%, p < 0.0001; 0.20 [0.04-0.91]. One case of postpartum haemorrhage was prevented for every 18 women treated. Misoprostol was also associated with a decrease in mean postpartum blood loss (262.3 mL to 214.3 mL, p < 0.0001). Postpartum haemorrhage rates fell over time in both groups but remained significantly higher in the placebo group. Women taking misoprostol. had a higher rate of transitory symptoms of chills and fever than the control. Interpretation Oral misoprostol was associated with significant decreases in the rate of acute postpartum haemorrhage and mean blood loss. The drug's low cost, ease of administration, stability, and a positive safety profile make it a good option in resource-poor settings.
引用
收藏
页码:1248 / 1253
页数:6
相关论文
共 50 条
  • [1] A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage
    Al-Sawaf, A.
    El-Mazny, A.
    Shohayeb, A.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 33 (03) : 277 - 279
  • [2] Randomised Controlled Trial of Sublingual and Rectal Misoprostol in the Prevention of Primary Postpartum Haemorrhage in a Resource-Limited Community
    Jacob Olumuyiwa Awoleke
    Benedict Tolulope Adeyanju
    Adebayo Adeniyi
    Olusola Peter Aduloju
    Babatunde Ajayi Olofinbiyi
    [J]. The Journal of Obstetrics and Gynecology of India, 2020, 70 : 462 - 470
  • [3] Randomised Controlled Trial of Sublingual and Rectal Misoprostol in the Prevention of Primary Postpartum Haemorrhage in a Resource-Limited Community
    Awoleke, Jacob Olumuyiwa
    Adeyanju, Benedict Tolulope
    Adeniyi, Adebayo
    Aduloju, Olusola Peter
    Olofinbiyi, Babatunde Ajayi
    [J]. JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2020, 70 (06): : 462 - 470
  • [4] Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial
    Walraven, G
    Dampha, Y
    Bittaye, B
    Sowe, M
    Hofmeyr, J
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2004, 111 (09) : 1014 - 1017
  • [5] Oral misoprostol for postpartum haemorrhage
    Weeks, Andrew
    [J]. LANCET, 2006, 368 (9553): : 2123 - 2123
  • [6] Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial
    Bellad, M. B.
    Tara, D.
    Ganachari, M. S.
    Mallapur, M. D.
    Goudar, S. S.
    Kodkany, B. S.
    Sloan, N. L.
    Derman, R.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (08) : 975 - 986
  • [7] A randomised controlled trial comparing the efficacy of intramuscular syntometrine and intravenous syntocinon, in preventing postpartum haemorrhage
    Rashid, M.
    Clark, A.
    Rashid, M. H.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 29 (05) : 396 - 401
  • [8] Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial
    Sringamwong, Wirawan
    Saokaew, Surasak
    Mongkhon, Pajaree
    [J]. ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [9] Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial
    Sringamwong, Wirawan
    Saokaew, Surasak
    Mongkhon, Pajaree
    [J]. ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [10] SUBLINGUAL MISOPROSTOL FOR PREVENTING POSTPARTUM HAEMORRHAGE: A SYSTEMATIC REVIEW
    Hoefler, R.
    Silva, M.
    Galvao, T.
    Zaconeta, A.
    Pereira, M.
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A144 - A144